Introduction
Schistosomiasis still remains a great challenge to medicinal chemists as no antischistosomal drug has yet emerged, that could gain general acceptance and wide-spread use [1] . Impairment of both parasite and host normal metabolic processes and frequent hepatotoxic long-term effects have raised doubts about the real effectiveness and safety of even such accepted drugs as Niridazole (Ambilhar®) and Lucanthone (Meracil-D®) [2, 3] .
Among the vast collection of novel drugs, that have shown potentially useful antischistosomal activity, Furapromidium (I) has been ascribed with unusual promise [4] , The early introduction of this simple amide into oral chemotherapy of bilhariasis in China has motivated the synthesis and antischistosomal testing of several acrylamides of other nitro heterocycles [5, 6] . For the monocyclic heterosystems investigated, antischistosomal activity was shown to be markedly affiliated to the ease of the reduction of the 5-nitroheterocycle residue during its interaction with the biologic receptors of the schistosome. In this concern, the significance of the 2-acrylamide moiety for the antischistosomal activity of Furapromidium (I) is supposed to involve definite electronic +M contributions, that lead to activation of the 5-nitrofuran function of I as a reducible centre [7] . Although several benzimidazole derivatives such as Thiabendazol, Mebendazol and Cambendazol are widely used as efficient anthelmintics [8, 9] , the antischistosomal potentiality of nitrobenzimidazolylacrylic acid derivatives remains so far unexplored. In fact, such derivatives are not yet reported. 
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Results and Discussion
The route adopted for the synthesis of the designed acrylamide derivatives involved the following transformations, Scheme 1.
l,2-Dimethyl-5-nitrobenzimidazole [10] was oxidized with selenium dioxide in dioxane at 100 °C to l-methyl-5-nitrobenzimidazole-2-carboxaldehyde (1). The NMR, IR and MS data of this compound are in full agreement with its structure. Previously, this aldehyde was reported as the product of similar oxidation of l,2-dimethyl-5-nitrobenzimidazole in boiling toluene [11] , however with a totally different melting point (188 °C) than that determined in the current investigation (223 °C). The lack of structural evidence for the toluene-method oxidation product makes its actual nature questionable.
The synthesis of 3-(l-methyl-5-nitro-2-benzimidazolyl)acrylic acid (2) was achieved through condensation of aldehyde (1) with malonic acid under the conditions of the Knövenagel-Döbner reaction [12] . That the obtained acrylic acid derivative exists as the E-isomer is established from its NMR spectrum, that showed the AB system of the -CH = CHCOOH function as a pair of doublets with a typical J -value (16 cps) of trans proton coupling [13] . Our trials to synthesize compound 2 by condensation of 1,2-dimethyl-5-nitrobenzimidazole with chloral hydrate and subsequent alkaline hydrolysis of the condensation product were almost futile; most of the starting benzimidazole derivative was recovered unreacted.
The ester and amide derivatives (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) of the newly synthesized acrylic acid derivative (2) were readily prepared by reacting the acid with the appropriate alcohol or amine derivative in the presence of sulfuric acid or N-ethoxycarbonyl-2-ethoxydihydroquinoline (EEDQ) respectively. The latter has been frequently employed as a convenient coupling reagent for peptide synthesis [14] . Apart from its superiority to dicyclohexylcarbodiimide, which failed to bring about the amidation of 2, EEDQ by-products (quinoline and CO2) offered no problems during the separation of the produced acrylamide derivatives, compounds 6-20.
The structure of the obtained acrylic acid ester and amide derivatives was confirmed by microanalytical as well as by NMR and IR spectral data, that revealed the exclusive existence of these derivatives as the trans form. Preliminary parasitological investigation of compounds 3-20 as potential antischistosomal agents is in progress.
Experimental
Melting points were obtained by means of a MelTemp block and are uncorrected. Elemental microanalyses, IR, NMR, and MS measurements were performed at Institut für Pharmazeutische Chemie, Münster, West Germany and Faculty of Science, Cairo, Egypt, using Perkin-Elmer autoanalyzer, IR-237 Perkin-Elmer, Varian A-60 and Hitachi-PE MS appliances. Intermediate EEDQ was prepared as reported [15] .
-Methyl-5-nitrobenzimidazole-2-carboxaldehyde (1)
A solution of 0.11 mole of l,2-dimethyl-5-nitrobenzimidazole in 500 ml of dioxane was treated, while effectively stirred, with 0.15 mole of finely powdered selenium dioxide over a period of 30 min. 
Alkyl 3-(l-methyl-5-nitro-2-benzimidazolyl)• acrylates (3-5, Table I)
To a suspension of 0.01 mole of compound 2 in 25 ml of the appropriate alcohol was added 5.0 ml of H2SO4 (d, 1.84) and the reaction mixture refluxed for 5 h. The clear solution when cooled and carefully neutralized with 10% aqueous Na2C03 solution afforded the corresponding ester as a colorless crystalline product.
3-( l-Methyl-5-nitro-2-benzimidazolyl
)acrylamides (6-20, Table I )
To a solution of 0.003 mole of pure 2 in 30 ml of dimethylformamide was added an equimolar amount of EEDQ in 25 ml of absolute ethanol. The solution was left at ambient temperature for ca. 10 min, 0.003 mole of the appropriate amine added and the reaction mixture was refluxed for 2 h. The crude amides were readily obtained as yellow-orange colored precipitates when dimethylformamide was removed in vacuum, and the concentrate left was diluted with water. Recrystallization was effected using the proper solvents, Table I . 
